Search

Your search keyword '"Grayson, Peter C."' showing total 347 results

Search Constraints

Start Over You searched for: Author "Grayson, Peter C." Remove constraint Author: "Grayson, Peter C." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
347 results on '"Grayson, Peter C."'

Search Results

1. Automated Plaque Detection and Agatston Score Estimation on Non-Contrast CT Scans: A Multicenter Study

4. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

5. Spectrum of clonal hematopoiesis in VEXAS syndrome

6. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

7. Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis

9. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

12. Development of the Takayasu's Arteritis Integrated Disease Activity Index

15. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

17. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism

21. Clonal Hematopoiesis in a Broad Age Spectrum of Systemic Vasculitis

22. Eosinophilia in Vexas Syndrome: Expanding Hematologic Phenotype

23. DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways

24. Clonal Hematopoiesis in Vexas Syndrome

25. Thrombotic Manifestations in Patients with Vexas Syndrome

27. Reply

28. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

31. Reply.

32. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study.

33. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis

34. Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis.

36. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

37. VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With Vasculitis

38. Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu’s arteritis

39. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐CenterProspective Study

41. Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study

44. 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis.

45. 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis.

47. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

48. Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis

49. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

50. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Catalog

Books, media, physical & digital resources